The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 33 | — | 20.1x | Below average | |
Growth | 38 | 0.0% | 5.6% | Near average | |
Quality | 32 | -144.8% | 7.6% | Below average | |
Safety | 49 | 0.4x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 16 | — | — | Below average | |
Sentiment | 52 | — | — | Near average |
ASCENTAGE PHARMA GROUP INTERNATIONAL is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy ASCENTAGE PHARMA GROUP INTERNATIONAL shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Ascentage Pharma stock experienced a downward adjustment in its average price target by 6.24% over the past week, with the consensus dropping from 45.33 to 42.5. This change coincided with an increase in the number of analysts covering the stock from one to three, leading to a narrowing of the dispersion range between the high (45) and low (40). Despite this technical reduction in targets, qualitative assessments remain positive with continued 'Buy' and 'Outperform' ratings from major institutions such as Deutsche Bank and Oppenheimer.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.